Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues?
[Cannabinoid drugs for neurological diseases: what is behind?].
Santhera Receives European Marketing Authorization for Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
MAIT cells in autoimmunity.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
Transverse myelitis.
Breastfeeding is associated with lower risk for multiple sclerosis.
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.
NAD⁺ in aging, metabolism, and neurodegeneration.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Time to see the light.
Is multiple sclerosis an autoimmune disease?
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.

Pages